Comparative pharmacokinetics of Aspegic 1000 mg i.v. versus 1000 mg i.m. thrice daily

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 21, Issue 4, 1996, Pages 333-338

  Nia, B ^a   Vergnaud, J M ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

Author keywords

Aspegic; i.v. i.m. comparison; Modelling; Pharmacokinetics; Single and multiple dose

Indexed keywords

LYSINE ACETYLSALICYLATE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG RESPONSE; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MATHEMATICAL MODEL;

EID: 0030503196     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03189735     Document Type: Article

References (20)

1. Bannwarth B., Demotes-Mainard F., Schaeverke T., Labat L., Dehais J. (1995) Central analgesic effects of aspirin-like drugs. Fundam. Clin. Pharmacol., 9, 1-17.
2. Henry P., Hiesse-Prevost O., Dillenschneider A., Ganry H., Insuasty J. (1983) Efficacy and tolerance of effervescent aspirin-metoclopramide association in the treatment of migraine attack. La presse Medicale, 24, 254-258.
3. Castaneda-Hernandez G., Castillo-Mendez M.S., Lopez-Munoz F.J., Granados-Soto V., Flores-Murietta F.J., (1994) : Potentiation by caffeine of the analgesic effect of aspirin in the pain-induced functional impairment model in the rat. Can. J. Physiol. Pharmacol., 72, 1127-1131.
4. Forster C., Anton F., Reek P.W., Weber E., Handwerker H.O. (1988) : Measurement of the analgesic effects of aspirin with a new experimental analgesimetric procedure. Pain, 32, 215-222.
5. Derumeaux G., Mouton-Schleifer D., Soyer R., Saoudi N., Cribier A., Letac B. (1995) : High incidence of left atrial thrombus detected by transoesophageal endocardiography in heart transplant recipients. Eur. Heart J., 16, 120-125.
6. Henneken C.H. (1990) : Role of aspirin with thrombolytic therapy in acute myocardial infarction. Chest, 97, 1515-1555.
7. Rudra A. (1989) : Injectable aspirin: attenuation of the cardiovascular response to tracheal intubation. Calcutta Med. J. 5, 39-42.
8. antihypertensive effect of aspirin in rats. Br. J. Pharmacol., 94, 755-758.
9. Willerson J.T., Mueller S.D., Ferguson J.J. (1992) : Should all patients with risk factors for ischemic heart disease receive aspirin Texas Heart Inst. J., 19, 73-78
10. Duc J., Pecoud A. (1988) : About one case of respiratory arrest: aspirin and non steroidal anti-inflammatory drugs tolerance. Med. Hygiene, 46, 705-709.
11. De Gaetano G., Cerletti C. (1988) : Prolonging of bleeding time by aspirin: a dual mechanism. Thrombosis Res., 50, 907-912.
12. Gay W.A.J.R. (1990) : Aspirin, blood loss and transfusion. Ann. Thorac. Surg., 50, 345.
13. Van Gijn J. (1992) : Aspirin: dose and indications in modern stroke preventions. Neurol. Clinics, 10, 193-207.
14. Pappas J.M., Westengard J.C., Bull B.S. (1976) : Population variability in the effect of aspirin on platelet function: implications for clinical trials and therapy. Arch. Pathol. Lab. Med., 118, 801-804.
15. Shah A., Lettieri J., Kaiser L., Echols R., Heller A.H. (1994) : Comparative pharmacokinetics and safety of ciprofloxacin 400 mg i.v. thrice daily versus 750 mg p.o. twice daily. J. Antimicrob. Chemother., 33, 795-801.
16. Catchpole C., Andrews J.M., Woodcock J., Wise R. (1994) : The comparative pharmacokinetics and tissue penetration of single-dose ciprofloxacin 400 mg i.v. and 750 mg p.o. J. Antimicrob. Chemother., 33, 103-110.
17. Vergnaud J.M. (1993) : Controlled Drug Release of oral Dosage Forms. E. Horwood, chapters 10-15.
18. Waremboorg H., Delbecque H., Fruchart J.Ch. (1975) : Dosage de la salicylèmie chez l'homme après administration d'acetylsalicylate de lysine par voie intraveineuse et par voie intramusculaire. Lille Med., 20, 923-927.
19. Warembourg H., Delbecque H., Ducloux G. (1974) : Appreciation des effets d'un sel injectable de l'acide acetylsalicyque chez des malades soumis à des traitements anticoagulants. Lille Med., 21, 632-638.
20. Vidal, Editions du Vidal, Paris (1994) Aspegic, 112.